Evidence map›Paper›PMID 34248551›Full record

ArticleCase reports in oncology

Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy.

Toru Matsugasumi, Koji Masui, Kaori Yamada, Sho Watanabe, Koji Okihara, Nana Kozawa, Yasuhiro Yamada, Hideya Yamazaki, Kei Yamada, Osamu Ukimura

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Toru MatsugasumiDepartment of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Koji MasuiDepartment of Radiation Oncology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Kaori YamadaDepartment of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sho WatanabeDepartment of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Koji OkiharaDepartment of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nana KozawaDepartment of Radiology, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Yasuhiro YamadaDepartment of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hideya YamazakiDepartment of Radiation Oncology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Kei YamadaDepartment of Radiation Oncology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Osamu UkimuraDepartment of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kyoto Prefectural University of Medicine · JPKyoto first Red Cross hospital · JPKyoto Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who developed pSCC 8 years after LDR-BT. He was subsequently selected to receive a combined multimodal treatment with high-dose-rate interstitial brachytherapy (HDR-ISBT), external beam radiation therapy, and chemotherapy for his pSCC. Eleven months later, he displayed no biochemical failure nor clinical radiographic recurrence. However, MRI detected a newly developed prostatic-rectal fistula (grade 4), and a colostomy was performed to relieve pain and inflammation. To our knowledge, this is the first report to perform a combined multimodal treatment with HDR-ISBT for pSCC suspected as a secondary cancer due to LDR-BT.

Indexed as

High-dose-rate interstitial brachytherapyProstate cancerProstate squamous cell carcinoma

Identifiers

PMID34248551
PMCPMC8255723
OpenAlexW3171225833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.